The contribution of [1H] magnetic resonance spectroscopy to the study of excitation-inhibition in autism
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) affects over 1:100 of the population and costs the UK more than £32bn and the USA more than $175bn (£104bn) annually. Its core symptoms are social and communication difficulties, repetitive behaviours and sensory hyper- or hypo-sensitivities. A highly diverse phenotypic presentation likely reflects its etiological heterogeneity and makes finding treatment targets for ASD challenging. In addition, there are no means to identify biologically responsive individuals who may benefit from specific interventions. There is hope however, and in this review we consolidate how findings from magnetic resonance spectroscopy (MRS) add to the evidence that differences in the brain's excitatory glutamate and inhibitory γ-aminobutyric acid (GABA) balance may be both a key biomarker and a tractable treatment target in ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 3×
“Lower levels of FMRP are found in individuals with idiopathic ASD (i.e. ASD without a known cause) who have a concomitant increase in mGluR5 (Fatemi et al., 2011; Fatemi and Folsom, 2011).”
Model of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · cited 2×
“, 2007), E-I imbalance has been suggested to be a ‘common final pathway’ in ASD (Nelson and Valakh, 2015; Rubenstein and Merzenich, 2003).”
Neocortical excitation/inhibition balance in information processing and social dysfunction
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 1×
“FMRP negatively regulates postsynaptic glutamate receptor synthesis (including metabotropic glutamate receptor 5; mGluR5) by binding to ribosomes and stalling translation of target mRNAs (Darnell et al., 2011).”
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851 · cited 1×
“…non-uniform water suppression and voxel bleeding artefact (i.e. signal contamination from neighbouring voxels into the voxel-of-interest), therefore single voxel [1H]MRS remains the technique of choice (Astrakas and Argyropoulou, 2016; Blüml, 2013; Duarte et al., 2012; Jansen et al., 2006).”
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 2×
“These molecules anchor pre- and post-synaptic neuron terminals and disruptions of the molecular assembly of the synapse can potentially cause E-I imbalance (Futai et al., 2007; Südhof, 2008).”
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 1×
“mRNA translation at the synapse is then increased (Bear et al., 2004), leading to excess excitatory activity, enhanced long term depression, and ASD-like pathology in animal models (Lozano et al.”
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“By definition, ASD is a neurodevelopmental condition and how the brain matures is acknowledged to be quite different to even age matched controls (Amaral et al., 2008; Aoki et al., 2012; Redcay and Courchesne, 2005).”
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.210 · Cited by 1,296
Muhle, R., Trentacoste, S. V., & Rapin, I. (2004) · Pediatrics · doi:10.1542/peds.113.5.e472 · Cited by 1,207 · cited 1×
“Indeed, based on observations such as an increased incidence of epilepsy – a disorder of E-I balance – in individuals with ASD (Bolton et al., 2011; Muhle et al., 2004), and post-mortem evidence of altered expression of proteins involved in glutamate and GABA biosynthesis and neurotransmission in the brains of individ…”
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders
Nelson, S. B., & Valakh, V. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.033 · Cited by 1,001
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis
Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K., & Südhof, T. C. (2003) · Nature · doi:10.1038/nature01755 · Cited by 699 · cited 1×
“Consistent with this, neurexin 1-α (Nrxn1-α) knock-out mice show a reduction in spontaneous and evoked neurotransmitter release (Kattenstroth et al., 2004; Missler et al., 2003; Zhang, 2005) accompanied by behavioural abnormalities that resemble some of the”
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., & Pevsner, J. (2001) · Neurology · doi:10.1212/wnl.57.9.1618 · Cited by 518
Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516 · cited 1×
“How these diverse E-I anomalies might act mechanistically has been the subject of a number of recent comprehensive reviews (Foss-Feig et al., 2017; Gao and Penzes, 2015; Gatto and Broadie, 2010; Lee et al., 2017; Mullins et al., 2016; Nelson and Valakh, 2015; Uzunova et al., 2016).”
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500
GABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439
Orefice, L. L., Zimmerman, A. L., Chirila, A. M., Sleboda, S. J., Head, J. P., & Ginty, D. D. (2016) · Cell · doi:10.1016/j.cell.2016.05.033 · Cited by 383
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?
MEYER, U., FELDON, J., & DAMMANN, O. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212c196 · Cited by 357 · cited 2×
“…to maternal inflammation or the anti-epilepsy medication valproate, disrupt gene and protein expression across GABA pathways and trigger behavioural features which mimic the human condition (Fatemi et al., 2008; Fukuchi et al., 2009; Giovanoli et al., 2014; Meyer et al., 2011; Wei et al., 2016).”
Reduced GABAergic Action in the Autistic Brain
Robertson, C. E., Ratai, E.-M., & Kanwisher, N. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.019 · Cited by 327
Selimbeyoglu, A., Kim, C. K., Inoue, M., Lee, S. Y., Hong, A. S. O., Kauvar, I., Ramakrishnan, C., Fenno, L. E., Davidson, T. J., Wright, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6733 · Cited by 326 · cited 1×
“…shown that reducing the E-I ratio by either reducing the excitability of pyramidal neurons or by increasing the excitability of inhibitory parvalbumin-positive neurons in the mPFC rescued social deficits in mice lacking the CNTNAP2 gene, which has been implicated in ASD (Selimbeyoglu et al., 2017).”
A randomised controlled trial of bumetanide in the treatment of autism in children
Lemonnier, E., Degrez, C., Phelep, M., Tyzio, R., Josse, F., Grandgeorge, M., Hadjikhani, N., & Ben-Ari, Y. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.124 · Cited by 322
Epilepsy in autism: features and correlates
Bolton, P. F., Carcani-Rathwell, I., Hutton, J., Goode, S., Howlin, P., & Rutter, M. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076877 · Cited by 281 · cited 1×
“Indeed, based on observations such as an increased incidence of epilepsy – a disorder of E-I balance – in individuals with ASD (Bolton et al., 2011; Muhle et al., 2004), and post-mortem evidence of altered expression of proteins involved in glutamate and GABA biosynthesis and neurotransmission in”
Demetriou, E. A., DeMayo, M. M., & Guastella, A. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00753 · Cited by 274
Gaetz, W., Bloy, L., Wang, D. J., Port, R. G., Blaskey, L., Levy, S. E., & Roberts, T. P. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.068 · Cited by 267 · cited 3×
“, 2014), whereas others have observed no differences in GABA+ in the prefrontal and occipital cortices (Ajram et al., 2017; Brix et al., 2015; Cavalho Pereira et al., 2018; Cochran et al., 2015; Drenthen et al., 2016; Gaetz et al., 2014; Goji et al., 2017; Horder et al., 2018; Puts et al., 2017; Robertson et al., 2015…”
Kaiser, L. G., Schuff, N., Cashdollar, N., & Weiner, M. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.001 · Cited by 251 · cited 1×
“For example, [1H]MRS measures of glutamate and GABA+ differ even within the typically developing population (Bogner et al., 2010; Brix et al., 2017; Kaiser et al., 2005; O'Gorman et al., 2011; Sailasuta et al., 2008).”
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., Huang, H., Oishi, K., Mori, S., Smee, D. F., Pearce, D. A., Winter, C., Sohr, R., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.018 · Cited by 250 · cited 1×
“…to maternal inflammation or the anti-epilepsy medication valproate, disrupt gene and protein expression across GABA pathways and trigger behavioural features which mimic the human condition (Fatemi et al., 2008; Fukuchi et al., 2009; Giovanoli et al., 2014; Meyer et al., 2011; Wei et al., 2016).”
Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., & Matsuda, T. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1065-0 · Cited by 231
Gatto (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00004 · Cited by 204 · cited 1×
“How these diverse E-I anomalies might act mechanistically has been the subject of a number of recent comprehensive reviews (Foss-Feig et al., 2017; Gao and Penzes, 2015; Gatto and Broadie, 2010; Lee et al., 2017; Mullins et al., 2016; Nelson and Valakh, 2015; Uzunova et al., 2016).”
Decreased GABA B receptors in the cingulate cortex and fusiform gyrus in Autism
Oblak, A. L., Gibbs, T. T., & Blatt, G. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06858.x · Cited by 203
Lozano, R., Rosero, C. A., & Hagerman, R. J. (2014) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2014.01022 · Cited by 186 · cited 1×
“, 2004), leading to excess excitatory activity, enhanced long term depression, and ASD-like pathology in animal models (Lozano et al., 2014; Yu and Berry-Kravis, 2014).”
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167 · cited 1×
“How these diverse E-I anomalies might act mechanistically has been the subject of a number of recent comprehensive reviews (Foss-Feig et al., 2017; Gao and Penzes, 2015; Gatto and Broadie, 2010; Lee et al., 2017; Mullins et al., 2016; Nelson and Valakh, 2015; Uzunova et al., 2016).”
Urraca, N., Cleary, J., Brewer, V., Pivnick, E. K., McVicar, K., Thibert, R. L., Schanen, N. C., Esmer, C., Lamport, D., & Reiter, L. T. (2013) · Autism Research · doi:10.1002/aur.1284 · Cited by 164 · cited 1×
“For example, studies of ASD susceptibility genes have repeatedly identified chromosome 15q11-13 as a particular region of interest as 1–3% of all ASD cases were reported to be associated with duplications in this region (Moreno-De-Luca et al., 2013; Urraca et al., 2013).”
Moreno-De-Luca, D., Sanders, S. J., Willsey, A. J., Mulle, J. G., Lowe, J. K., Geschwind, D. H., State, M. W., Martin, C. L., & Ledbetter, D. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.138 · Cited by 161
Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J., & Südhof, T. C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.182 · Cited by 140
Port, R. G., Gaetz, W., Bloy, L., Wang, D., Blaskey, L., Kuschner, E. S., Levy, S. E., Brodkin, E. S., & Roberts, T. P. L. (2017) · Autism Research · doi:10.1002/aur.1686 · Cited by 94 · cited 4×
“…the sensorimotor regions, anterior cingulate cortex and cerebellum (Gaetz et al., 2014; Harada et al., 2011; Ito et al., 2017; Kubas et al., 2012; Port et al., 2017; Puts et al., 2017; Rojas et al., 2014), whereas others have observed no differences in GABA+ in the prefrontal and occipital…”
InfluentialFatemi, S. H., & Folsom, T. D. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-6 · Cited by 84
Metabolite alterations in autistic children: a 1H MR spectroscopy study
Kubas, B., Kułak, W., Sobaniec, W., Tarasow, E., Łebkowska, U., & Walecki, J. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0014-x · Cited by 74 · cited 4×
“The initial studies focused on the glutamatergic system, reporting Glx and glutamate (Glu), with reduced levels found in the cortical grey matter, frontal lobes, thalamus and cerebellum in children with ASD (DeVito et al., 2007; Hegarty et al., 2017; Kubas et al., 2012) (Table 1).”
InfluentialChaste, P., Sanders, S. J., Mohan, K. N., Klei, L., Song, Y., Murtha, M. T., Hus, V., Lowe, J. K., Willsey, A. J., Moreno‐De‐Luca, D., et al. (2014) · Autism Research · doi:10.1002/aur.1378 · Cited by 61 · cited 1×
“Mutations in this region, especially in the β3 subunit, convey a high risk for ASD and have been linked to repetitive symptoms and insistence on sameness (Chaste et al., 2014; Isles et al., 2016; Shao et al., 2003).”
Atypical developmental patterns of brain chemistry in children with Autism Spectrum Disorder
Corrigan, N. M., Shaw, D. W. W., Estes, A. M., Richards, T. L., Munson, J., Friedman, S. D., Dawson, G., Artru, A. A., & Dager, S. R. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1388 · Cited by 54
Cited by
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Demetriou, E. A., DeMayo, M. M., & Guastella, A. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00753 · Cited by 274
“More excitation is theorized to represent greater activity, while greater inhibition suggests decreased cortical activity (94).”
BackgroundFetit, R., Hillary, R. F., Price, D. J., & Lawrie, S. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.014 · Cited by 148
Pierce, S., Kadlaskar, G., Edmondson, D. A., McNally Keehn, R., Dydak, U., & Keehn, B. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-09351-0 · Cited by 42
“Although in vivo measurement of GABA and glutamate concentrations using magnetic resonance spectroscopy (MRS) has provided mixed results (see [32], for review), region-specific differences in GABA concentrations in ASD have been linked to sensory processing differences [33–35].”
Metadata
- Authors
- Ajram, L. A., Pereira, A. C., Durieux, A. M. S., Velthius, H. E., Petrinovic, M. M., & McAlonan, G. M.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 89
- Pages
- 236-244
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2893819854
- Cited by
- 74
- References
- 40
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.